Hilary Baker-Jennings

Hilary Baker-Jennings counsels life sciences and technology companies on general corporate and securities matters, including representing early- and late-stage private companies in a variety of venture capital and other financing transactions, and advising public companies on capital markets transactions and ongoing disclosure and compliance. Over the last several years, she has advised clients such as Constellation Pharmaceuticals, Editas Medicine, Flare Therapeutics, Flo Health, Gradient AI, Rectify Pharmaceuticals and Sage Therapeutics on a number of transformative transactions, including IPOs, follow-on offerings and significant venture financings. She has also represented multiple leading investment banks as underwriters’ counsel.